Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy.
- DOI
- 10.1016/j.apsb.2026.06.022
- Published
- 2026 Sep
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.06.022,
title = {Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy.},
author = {Lai HT and Dias-Pedroso D and Da Costa MEM and Fernandes R and Nguyen TNA and Bawa O and Khneisser P and Silva JG and Khalij Y and Campanella M and Jones JG and Dokudovskaya S and Kroemer G and Marchais A and Gaspar N and Geoerger B and Diane O and Mazzanti L and Duong TH and Lewin G and Ferrié L and Figadère B and Brenner C},
year = {2026},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2026.06.022},
url = {https://doi.org/10.1016/j.apsb.2026.06.022}
}RIS
TY - JOUR TI - Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy. AU - Lai HT AU - Dias-Pedroso D AU - Da Costa MEM AU - Fernandes R AU - Nguyen TNA AU - Bawa O AU - Khneisser P AU - Silva JG AU - Khalij Y AU - Campanella M AU - Jones JG AU - Dokudovskaya S AU - Kroemer G AU - Marchais A AU - Gaspar N AU - Geoerger B AU - Diane O AU - Mazzanti L AU - Duong TH AU - Lewin G AU - Ferrié L AU - Figadère B AU - Brenner C PY - 2026 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2026.06.022 UR - https://doi.org/10.1016/j.apsb.2026.06.022 ER -
APA
HT, L., D, D., MEM, D. C., R, F., TNA, N., O, B., P, K., JG, S., Y, K., M, C., JG, J., S, D., G, K., A, M., N, G., B, G., O, D., L, M., TH, D., G, L., L, F., B, F., & C, B. (2026). Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.06.022
Source records
- pubmed · retrieved 2026-09-25T09:22:18.725Z